Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene

Nidaa A. Ababneh(University of Jordan), Abdalla Awidi(University of Jordan), Ban Al-Kurdi(University of Jordan), Nour Sharar(Hamad bin Khalifa University), Dema Ali(University of Jordan), Omar Qanno'(University of Jordan), Abdee T. Ryalat(King Hussein Cancer Center), Bareqa Salah(University of Jordan), Raghda Barham(University of Jordan)
Stem Cell Research
August 31, 2020
10.1016/j.scr.2020.101967
Cited by 4

Related Papers

siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
<i>C9orf72</i> Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
|Stem Cells|2016|248
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123
Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial
|Urologia Internationalis|2018|109